You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. NDT of Fracture Toughness for Pipeline Steels

    SBC: FBS INC            Topic: 180PH1

    Fracture toughness is the material parameter that, along with applied loading and flaw geometry, dictates the critical crack size, and therefore controls the flaw size that must be detected during inspections. A major challenge facing pipeline operators is that many pipelines are old, making their structural integrity uncertain, and that material pedigree of the pipeline steel is unknown. Therefor ...

    SBIR Phase II 2020 Department of Transportation
  2. MyHealthyPregnancy mobile health app: Combining behavioral science and machine learning for risk communication during the peripartum period

    SBC: Naima Health LLC            Topic: NCCDPHP

    ABSTRACT: Depression during pregnancy affects approximately 10% of women and is related to low birthweight and preterm birth. Similarly, up to 9% of pregnant women experience intimate partner violence (IPV) and abuse, with over 41% of assaults resulting in physical injury, and almost 30% requiring medical treatment. When untreated, these risks cost health systems at least $50B/year. Mitigation has ...

    SBIR Phase II 2020 Department of Health and Human ServicesCenters for Disease Control and Prevention
  3. Optimization of LGM2605 for use as a device in lung transplant

    SBC: Lignamed, LLC            Topic: NHLBI

    LignaMed, LLC is developing a novel small molecule device, LGM2605, that will be utilized and administered via FDA approved ex vivo lung perfusion (EVLP), to improve lung function parameters of ex vivo donor lungs in advance of transplant surgery. Per FDA device regulations LGM2605 will be fully cleared from the donor lung prior to transplant. This work supports the efforts of the NHLBI to promote ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  4. Oral PCSK9/LDLR antagonist direction to the clinic

    SBC: SHIFA BIOMEDICAL CORPORATION            Topic: NHLBI

    Project Summary/Abstract Heart disease has been the leading cause of death in the United States and the world for more than a century, ever since the early 1900s. About 610,000 people die of heart disease in the United States every year–thatandapos;s 1 in every 4 deaths. The epidemic burden is enormous; in 2016, cardiovascular disease (CVD) cost $555 billion in the US alone, and by 2035, the cos ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  5. Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders

    SBC: INTEGRAL MOLECULAR INC            Topic: 400

    ABSTRACT T cell-mediated autoimmune and chronic inflammatory diseases affect 23 million Americans, corresponding to ~$100B/year in direct healthcare costs. Pharmaceutical advances have enabled the development of treatments for these diseases, but existing drugs have severe immune- compromising side effects because they broadly target all T cell activity. The voltage-gated ion channel Kv1.3 is a va ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  6. Myocardial Delivery of MMP Inhibiting Hydrogels

    SBC: Prohibix, LLC            Topic: NHLBI

    ABSTRACTOver 3 million people in the United States currently suffer from heart failure caused by a myocardial infarction (MI) and more than 600,000 survivable MIs occur each year, including 200,000 ST-segment Elevated MIs (STEMIs). STEMIs are a severe MI caused by a prolonged period of blocked blood supply that affects a large area of the heart muscle. Re-hospitalization rates remain high for STEM ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  7. Paradigm Surgical Phase II-Development and Validation of SafeClose Roller Mesh Augmentation System for Hernia Treatment and Prevention

    SBC: Paradigm Surgical LLC            Topic: 300

    Paradigm Surgical Phase II–Development and Validation of SafeCloseTM Roller Mesh Augmentation System for Hernia PreventionEach year an estimated 153,000 cases of incisional hernia (IH) repairs are performed in the United States and over $7 billion is spent on hernia treatment. Mesh onlay, which involves fixating mesh onto the closed abdominal wall to reinforce the incision, is a procedure that w ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  8. Novel Expandable Infusion Catheter for the Treatment of Acute Pulmonary Embolism

    SBC: THROMBOLEX, INC.            Topic: NHLBI

    PROJECT SUMMARY—Thrombolex, Inc. has developed an intravascular catheter with an expandable spiral basket of infusion limbs to improve the efficacy of catheter-directed thrombolysis (CDT) in large vessels. Preclinical studies indicate administration of recombinant tissue plasminogen activator (rtPA) via the Bashir™ Endovascular Catheter (BEC) reduces thrombus burden to a greater degree than no ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  9. Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination

    SBC: QUANTUMBIO INC            Topic: 400

    The study of protein/ligand binding is one of the central problems in computational biology because of its importance in understanding intermolecular interactions, and because of its practical payoff in drug discovery efforts. The transformative impact accurate target/ligand structure can have in the design of next generation medicines cannot be overstated. If we could routinely and accurately des ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  10. Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery

    SBC: THE AMINO COMPANY LLC            Topic: 300

    7. Project Summary/Abstract Bariatric surgery has become a common treatment for severe obesity. While this results in the desired loss of fat mass, muscle mass is also lost with implications for post-surgical health benefits. It is our overarching premise that consumption of our essential amino acid (EAA)-based nutritional formulation following bariatric surgery will preserve muscle mass by stimul ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government